Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
42.62
+1.26 (3.05%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Medline Stock Forecast
Stock Price Forecast
The 23 analysts that cover Medline stock have a consensus rating of "Strong Buy" and an average price target of $50.48, which forecasts a 18.44% increase in the stock price over the next year. The lowest target is $40 and the highest is $60.
Price Target: $50.48 (+18.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Medline stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|
| Strong Buy | 7 | 8 | 8 |
| Buy | 12 | 12 | 12 |
| Hold | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 22 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +40.78% | Mar 11, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | +24.35% | Mar 10, 2026 |
| Tigress Financial | Tigress Financial | Strong Buy Maintains $55 → $60 | Strong Buy | Maintains | $55 → $60 | +40.78% | Mar 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +29.05% | Mar 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +22.01% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
31.51B
from 28.43B
Increased by 10.83%
Revenue Next Year
33.93B
from 31.51B
Increased by 7.68%
EPS This Year
1.49
from 1.43
Increased by 4.31%
EPS Next Year
1.68
from 1.49
Increased by 12.32%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 32.7B | 35.6B | |
| Avg | 31.5B | 33.9B | |
| Low | 30.0B | 32.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.9% | 12.9% | |
| Avg | 10.8% | 7.7% | |
| Low | 5.4% | 2.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.62 | 1.84 | |
| Avg | 1.49 | 1.68 | |
| Low | 1.36 | 1.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.0% | 23.1% | |
| Avg | 4.3% | 12.3% | |
| Low | -4.8% | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.